These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3482282)

  • 1. [A clinical study on combined lithium and carbamazepine treatment of major affective disorders].
    Chen CC; Ko WK
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Mar; 3(3):176-81. PubMed ID: 3482282
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
    Fritze J; Beneke M; Lanczik M; Schneider B; Walden J
    Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The lithium concentration of the blood plasma in combined therapy with lithium carbonate and carbamazepine].
    Skorik AI
    Farmakol Toksikol; 1991; 54(4):57-9. PubMed ID: 1786831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of carbamazepine in affective disorders].
    Beresewicz M
    Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan].
    Okuma T
    Seishin Shinkeigaku Zasshi; 2005; 107(5):415-22. PubMed ID: 15981617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report.
    Inoue K; Arima S; Tanaka K; Fukui Y; Kato N
    Folia Psychiatr Neurol Jpn; 1981; 35(4):465-75. PubMed ID: 6806160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical and follow-up study in 33 cases of rapid cyclic affective psychosis].
    Liu ZX; Wang DC
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):341-3, 383. PubMed ID: 1304996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness.
    Deiana V; Chillotti C; Manchia M; Pinna M; Ardau R; Del Zompo M; Severino G
    J Clin Psychopharmacol; 2011 Aug; 31(4):538-40. PubMed ID: 21720232
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
    Roick C; Ahrens B; Becker T
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
    Kaschka WP; Thürauf N; Mokrusch T; Korth M
    Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitization and oscillation following repeated stimulation: relationship to affective illness and its treatment with lithium and carbamazepine [proceedings].
    Post RM
    Psychopharmacol Bull; 1980 Oct; 16(4):50-2. PubMed ID: 7454937
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy for patients with mood disorders].
    Nomura S
    Seishin Shinkeigaku Zasshi; 2001; 103(12):1041-5. PubMed ID: 11925842
    [No Abstract]   [Full Text] [Related]  

  • 15. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset of lithium prophylaxis as a predictor of good long-term outcome.
    Franchini L; Zanardi R; Smeraldi E; Gasperini M
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(5):227-30. PubMed ID: 10591987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Labial herpes in patients with affective disorders receiving long-term lithium carbonate].
    Rybakowski J; Strzyzewski W; Zelechowska-Ruda E; Chłopocka-Woźniak M
    Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):215-7. PubMed ID: 8234051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum drug level monitoring in affective disorders.
    Krska J; Corner DA
    J Clin Pharm Ther; 1992 Dec; 17(6):357-63. PubMed ID: 1287028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders.
    Arató M; Rihmer Z; Felszeghy K
    Biol Psychiatry; 1980 Apr; 15(2):319-22. PubMed ID: 6251928
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid function during co-administration of lithium and carbamazepine compared to lithium alone.
    Vieweg WV; Godleski LS; Yank GR; Rowe WT; Hovermale LS
    Psychiatr Q; 1988; 59(1):69-72. PubMed ID: 3375393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.